TY - JOUR
T1 - Early identification of non-remission in first-episode psychosis in a two-year outcome study
AU - Simonsen, E.
AU - Friis, S.
AU - Opjordsmoen, S.
AU - Mortensen, E. L.
AU - Haahr, U.
AU - Melle, I.
AU - Joa, I.
AU - Johannessen, J. O.
AU - Larsen, T. K.
AU - Røssberg, J. I.
AU - Rund, B. R.
AU - Vaglum, P.
AU - McGlashan, T. H.
PY - 2010/11/1
Y1 - 2010/11/1
N2 - Objective: To identify predictors of non-remission in first-episode, non-affective psychosis. Method: During 4 years, we recruited 301 patients consecutively. Information about first remission at 3 months was available for 299 and at 2 years for 293 cases. Symptomatic and social outcomes were assessed at 3 months, 1 and 2 years. Results: One hundred and twenty-nine patients (43%) remained psychotic at 3 months and 48 patients (16.4%) remained psychotic over 2 years. When we compared premorbid and baseline data for the three groups, the non-remitted (n = 48), remitted for <6 months (n = 38) and for more than 6 months (n = 207), duration of untreated psychosis (DUP) was the only variable that significantly differentiated the groups (median DUP: 25.5, 14.4 and 6.0 weeks, respectively). Three months univariate predictors of non-remission were being single, longer DUP, core schizophrenia, and less excitative and more negative symptoms at baseline. Two-year predictors were younger age, being single and male, deteriorating premorbid social functioning, longer DUP and core schizophrenia. In multivariate analyses DUP, negative and excitative symptoms predicted non-remission at 3 months, but only DUP predicted at 2 years. Conclusion: Long DUP predicted both 3 month and 2-year non-remission rates in first-episode psychosis.
AB - Objective: To identify predictors of non-remission in first-episode, non-affective psychosis. Method: During 4 years, we recruited 301 patients consecutively. Information about first remission at 3 months was available for 299 and at 2 years for 293 cases. Symptomatic and social outcomes were assessed at 3 months, 1 and 2 years. Results: One hundred and twenty-nine patients (43%) remained psychotic at 3 months and 48 patients (16.4%) remained psychotic over 2 years. When we compared premorbid and baseline data for the three groups, the non-remitted (n = 48), remitted for <6 months (n = 38) and for more than 6 months (n = 207), duration of untreated psychosis (DUP) was the only variable that significantly differentiated the groups (median DUP: 25.5, 14.4 and 6.0 weeks, respectively). Three months univariate predictors of non-remission were being single, longer DUP, core schizophrenia, and less excitative and more negative symptoms at baseline. Two-year predictors were younger age, being single and male, deteriorating premorbid social functioning, longer DUP and core schizophrenia. In multivariate analyses DUP, negative and excitative symptoms predicted non-remission at 3 months, but only DUP predicted at 2 years. Conclusion: Long DUP predicted both 3 month and 2-year non-remission rates in first-episode psychosis.
KW - duration of untreated psychosis
KW - first-episode psychosis
KW - negative symptoms
KW - outcome
KW - premorbid functioning
UR - http://www.scopus.com/inward/record.url?scp=77957347115&partnerID=8YFLogxK
U2 - 10.1111/j.1600-0447.2010.01598.x
DO - 10.1111/j.1600-0447.2010.01598.x
M3 - Article
C2 - 20722632
AN - SCOPUS:77957347115
SN - 0001-690X
VL - 122
SP - 375
EP - 383
JO - Acta Psychiatrica Scandinavica
JF - Acta Psychiatrica Scandinavica
IS - 5
ER -